pantoprazole and semaglutide 📊 New findings from the 2024 REVISE Trial! reduces upper GI bleeding in ICU patients on mechanical ventilation, with no effect on mortality. 🏥 1.0% (pantoprazole) vs. 3.5% (placebo) for GI filter_sets bmi for glp-1 Patient Insuline Needles:10 needles +€2.00

pantoprazole and semaglutide 📊 New findings from the 2024 REVISE Trial! reduces upper GI bleeding in ICU patients on mechanical ventilation, with no effect on mortality. 🏥 1.0% (pantoprazole) vs. 3.5% (placebo) for GI filter_sets bmi for glp-1 Patient Insuline Needles:10 needles +€2.00

bmi for glp-1 Patient flow. BMI, body mass index; GLP‐1RA, glucagon‐like peptide‐1 The Promise of Injectable GLP-1 –

Future studies will investigate the effect of MariTide on cardiovascular disease, heart failure, chronic kidney disease, and obstructive sleep apnea

filter_sets

Insuline Needles:10 needles +€2.00

Its entry cuts Novo’s victory lap short, though Novo can still claim to have the only FDA-approved oral GLP-1